ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

EYPT EyePoint Pharmaceuticals Inc

12,12
0,03 (0,25%)
Última atualização: 15:26:39
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
EyePoint Pharmaceuticals Inc EYPT NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
0,03 0,25% 12,12 15:26:39
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
12,20 11,94 12,51 12,09
mais cotações »

Notícias Recentes

Data Hora Fonte Título
08/05/202408:00GLOBEEyePoint Pharmaceuticals Reports First Quarter 2024..
06/05/202408:00GLOBEEyePoint Pharmaceuticals Announces Topline Data from the..
16/04/202408:00GLOBEEyePoint Pharmaceuticals Reports Inducement Grants Under..
02/04/202408:00GLOBEEyePoint Pharmaceuticals Expands Scientific Advisory Board..
18/03/202408:00GLOBEEyePoint Pharmaceuticals Reports Inducement Grants Under..
07/03/202409:00GLOBEEyePoint Pharmaceuticals Reports Fourth Quarter and..
04/03/202409:00GLOBEEyePoint Pharmaceuticals Announces Appointment of Ramiro..
29/02/202409:00GLOBEEyePoint Pharmaceuticals to Report Fourth Quarter and..
27/02/202409:00GLOBEEyePoint Pharmaceuticals Announces Participation at Upcoming..
16/02/202409:00GLOBEEyePoint Pharmaceuticals Reports Inducement Grants Under..
03/02/202418:20GLOBEEyePoint Pharmaceuticals Announces Two Presentations of..
31/01/202409:00GLOBEEyePoint Pharmaceuticals to Present at the Guggenheim..
16/01/202409:00GLOBEEyePoint Pharmaceuticals Reports Inducement Grants Under..
10/01/202409:00GLOBEEyePoint Pharmaceuticals Announces First Patient Dosed in..
20/12/202309:00GLOBEEyePoint Pharmaceuticals to Present at the 42nd Annual J.P...
18/12/202309:00GLOBEEyePoint Pharmaceuticals Reports Inducement Grants Under..
08/12/202318:01GLOBEEyePoint Pharmaceuticals Announces Closing of Upsized Public..
05/12/202322:18GLOBEEyePoint Pharmaceuticals Announces Pricing of Upsized Public..
05/12/202308:25IHMARKETNEWSMoody’s Reassesses China, GitLab Exceeds Estimates, Twilio..
04/12/202318:06GLOBEEyePoint Pharmaceuticals Announces Proposed Public Offering..
04/12/202309:00GLOBEEyePoint Pharmaceuticals Announces Positive Topline Data..
16/11/202309:00GLOBEEyePoint Pharmaceuticals Reports Inducement Grants Under..
01/11/202308:00GLOBEEyePoint Pharmaceuticals Reports Third Quarter 2023..
31/10/202308:00GLOBEEyePoint Pharmaceuticals to Host Virtual Key Opinion Leader..
30/10/202308:00GLOBEEyePoint Pharmaceuticals Announces Presentations at..
25/10/202308:00GLOBEEyePoint Pharmaceuticals to Report Third Quarter 2023..
16/10/202308:00GLOBEEyePoint Pharmaceuticals Strengthens Board and Executive..
18/09/202308:00GLOBEEyePoint Pharmaceuticals Reports Inducement Grants Under..
11/09/202308:00GLOBEEyePoint Pharmaceuticals Reports Positive Masked Safety..
30/08/202308:00GLOBEEyePoint Pharmaceuticals Announces Participation at Upcoming..
16/08/202308:00GLOBEEyePoint Pharmaceuticals Reports Inducement Grants Under..
09/08/202308:00GLOBEEyePoint Pharmaceuticals to Present at the H.C. Wainwright..
02/08/202308:00GLOBEEyePoint Pharmaceuticals Reports Second Quarter 2023..
27/07/202308:00GLOBEEyePoint Pharmaceuticals Presents Interim Masked Safety Data..
26/07/202308:00GLOBEEyePoint Pharmaceuticals to Report Second Quarter 2023..
17/07/202308:00GLOBEEyePoint Pharmaceuticals Reports Inducement Grants Under..
05/06/202308:00GLOBEEyePoint Pharmaceuticals Completes Enrollment in Phase 2..
31/05/202308:00GLOBEEyePoint Pharmaceuticals to Present at the Jefferies..
18/05/202308:00GLOBEEyePoint Pharmaceuticals Announces Sale of YUTIQ® to Alimera..
16/05/202308:00GLOBEEyePoint Pharmaceuticals Reports Inducement Grants Under..